Our latest @ChemBioChem publication unveils the design of PROTACs targeting APT1. We demonstrate an integrated computational and experimental strategy for crafting selective PROTACs for APT1 within serine hydrolases. @IMMolecular @ChemCambridge https://t.co/z4HWayNZ4S
Still looking for a postdoc to work as part of IMPULSE – an EU funded project. May also contribute to other projects in the group leveraging results we will disclose in a Nature X journal (more on that soon... 🥳) 💻🤖
📢 I am looking for a #postdoc. Funding for 18 months.
Do you have expertise in #deeplearning – GNN and CNN in particular? This might be for you.
Main project is related to #multimodal learning for target ID . 🤖🤝🧪🤝🔬
If you want to know more reach out via DM.
Happy to share our work on a new multicomponent process merging the isonitrile-tetrazine (4+1) cycloaddition and the Ugi-4 component reaction. Congratulations to all authors @gbernardes_chem, @AldrinVasco, @tiago_medchem, @BilbaoChem
Our paper on the preclinical efficacy of a highly stable de novo protein decoy against SARS-CoV-2 infection is out! 🥳 @gbernardes_chem @ClaireTang20@AnaRaquelCoelh5@neoleukin @IMMolecular https://t.co/PaoXvrxaNm
Delighted to share the preclinical studies of JS25, a selective BTK inhibitor, with potent efficacy in blood cancers relative to other BTK inhibitors used in the clinic. A special thank you to all the collaborators and to my supervisor @gbernardes_chem.
https://t.co/apptYZFqOE